These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 29233480)

  • 1. Forecasting the prevalence of preclinical and clinical Alzheimer's disease in the United States.
    Brookmeyer R; Abdalla N; Kawas CH; Corrada MM
    Alzheimers Dement; 2018 Feb; 14(2):121-129. PubMed ID: 29233480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2009 Alzheimer's disease facts and figures.
    Alzheimer's Association
    Alzheimers Dement; 2009 May; 5(3):234-70. PubMed ID: 19426951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subtle Cognitive Decline and Biomarker Staging in Preclinical Alzheimer's Disease.
    Edmonds EC; Delano-Wood L; Galasko DR; Salmon DP; Bondi MW;
    J Alzheimers Dis; 2015; 47(1):231-42. PubMed ID: 26402771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk of progression of preclinical Alzheimer's disease stages: a systematic review and meta-analysis.
    Parnetti L; Chipi E; Salvadori N; D'Andrea K; Eusebi P
    Alzheimers Res Ther; 2019 Jan; 11(1):7. PubMed ID: 30646955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimated prevalence of Alzheimer's disease in the United States.
    Evans DA
    Milbank Q; 1990; 68(2):267-89. PubMed ID: 2233632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forecasting prevalence and mortality of Alzheimer's disease using the partitioning models.
    Akushevich I; Yashkin A; Kovtun M; Kravchenko J; Arbeev K; Yashin AI
    Exp Gerontol; 2023 Apr; 174():112133. PubMed ID: 36842469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of lifetime risks of Alzheimer's disease dementia using biomarkers for preclinical disease.
    Brookmeyer R; Abdalla N
    Alzheimers Dement; 2018 Aug; 14(8):981-988. PubMed ID: 29802030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2.
    Seshadri S; Beiser A; Au R; Wolf PA; Evans DA; Wilson RS; Petersen RC; Knopman DS; Rocca WA; Kawas CH; Corrada MM; Plassman BL; Langa KM; Chui HC
    Alzheimers Dement; 2011 Jan; 7(1):35-52. PubMed ID: 21255742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old.
    Brookmeyer R; Kawas CH; Abdallah N; Paganini-Hill A; Kim RC; Corrada MM
    Alzheimers Dement; 2016 Mar; 12(3):225-32. PubMed ID: 26900132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of the criteria for Alzheimer’s disease: A symposium.
    DeKosky ST; Carrillo MC; Phelps C; Knopman D; Petersen RC; Frank R; Schenk D; Masterman D; Siemers ER; Cedarbaum JM; Gold M; Miller DS; Morimoto BH; Khachaturian AS; Mohs RC
    Alzheimers Dement; 2011 Jan; 7(1):e1-12. PubMed ID: 21322828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.
    Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R;
    Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
    Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
    Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.
    Brookmeyer R; Gray S; Kawas C
    Am J Public Health; 1998 Sep; 88(9):1337-42. PubMed ID: 9736873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: preventing and recognizing a misdiagnosis.
    Mangino M; Middlemiss C
    Nurse Pract; 1997 Oct; 22(10):58-9, 63-8, 70, passim. PubMed ID: 9355117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revised criteria for mild cognitive impairment may compromise the diagnosis of Alzheimer disease dementia.
    Morris JC
    Arch Neurol; 2012 Jun; 69(6):700-8. PubMed ID: 22312163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease.
    Jack CR; Knopman DS; Weigand SD; Wiste HJ; Vemuri P; Lowe V; Kantarci K; Gunter JL; Senjem ML; Ivnik RJ; Roberts RO; Rocca WA; Boeve BF; Petersen RC
    Ann Neurol; 2012 Jun; 71(6):765-75. PubMed ID: 22488240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and sample size considerations for Alzheimer's disease prevention trials using multistate models.
    Brookmeyer R; Abdalla N
    Clin Trials; 2019 Apr; 16(2):111-119. PubMed ID: 30922116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population estimate of people with clinical Alzheimer's disease and mild cognitive impairment in the United States (2020-2060).
    Rajan KB; Weuve J; Barnes LL; McAninch EA; Wilson RS; Evans DA
    Alzheimers Dement; 2021 Dec; 17(12):1966-1975. PubMed ID: 34043283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2023 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2023 Apr; 19(4):1598-1695. PubMed ID: 36918389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2021 Alzheimer's disease facts and figures.
    Alzheimers Dement; 2021 Mar; 17(3):327-406. PubMed ID: 33756057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.